Osimertinib과 한약의 약물 상호작용 및 항암 효과에 대한 문헌 고찰 : 보중익기탕 및 황련해독탕을 중심으로

키워드

참고문헌 (31)

1. Bertino EM, "Phase IB study of osimertinib in combination with navitoclax in EGFR-mutant NSCLC", Clin Cancer Res, 27(6), pp.1604~1611 (2021)
2. "Osimertinib: uses, interactions, mechanism of action//DrugBank/" (2023)[URL]
3. Hermann R, "Clinical evidence of herbal drugs as perpetrators of pharmacokinetic drug interactions", Planta Med, 78(13), pp.1458~1477 (2012)
4. Wu X, "Effects of berberine on the blood concentration of cyclosporin A in renal transplanted recipients : clinical and pharmacokinetic study", Eur J Clin Pharmacol, 61(8), pp.567~572 (2005)
5. Seo MJ, "The current trend of research about Bojungikki-tang", J Korean Med Inst, 16(2), pp.83~90 (2010)
6. "Berberine-Osimertinib interaction"[URL]
7. Lee BJ, "Long-term progression-free survival in a patient with advanced non-small-cell lung cancer treated with low-dose gefitinib and traditional herbal medicine : A case report", Medicine, 100(5), pp.e24292~ (2021)
8. Zhou X, "Combination of Huanglian Jiedu Decoction and erlotinib delays growth and improves sensitivity of EGFR-mutated NSCLC cells in vitro and in vivo via STAT3", Bcl-2 signaling, 2021, pp.45(1), 217~229
9. Kim GH, "Case report of Korean medicine treatment of non-small cell lung cancer with pleural metastasis following targeted chemotherapy with afatinib", J Korean Med Internal Med, 41(6), pp.1255~1264 (2020)
10. Sim SH, "Traditional Korean medicine for skin toxic side effects from afatinib in a non-small cell lung cancer patient : A case report", J Korean Med Internal Med, 39(5), pp.973~983 (2018)
11. Wang Z, "An update on Chinese herbal medicines as adjuvant treatment of anticancer therapeutics", Biosci Trends, 12(3), pp.220~239 (2018)
12. Lee SY, "Inhibitory effects of Hwang-Ryun-Hae-Dok-Tang on cytochrome P450 in human liver microsomes", Xenobiotica, 45(2), pp.131~138 (2015)
13. Gomatou G, "Osimertinib resistance : molecular mechanisms and emerging treatment options", Cancers, 15(3), pp.841~ (2023)
14. Zhang X, "Alterations in the global proteome and phosphoproteome in third generation EGFR TKI resistance reveal drug targets to circumvent resistance", Cancer Res, 81(11), pp.3051~3066 (2021)
15. Leonetti A, "Resistance mechanisms to osimertinib in EGFR-mutated non-small cell lung cancer", Br J Cancer, 121, pp.725~737 (2019)
16. Fu K, "Therapeutic strategies for EGFR-mutated non-small cell lung cancer patients with osimertinib resistance", J Hematol Oncol, 15, pp.173~ (2022)
17. Yin Y, "A real-world pharmacovigilance study of FDA Adverse Event Reporting System(FAERS)events for osimertinib", Sci Rep, 12, pp.19555~ (2022)
18. Ahn L, "Bojungikgi-tang for chemotherapy-induced leukopenia : A systematic review and meta-analysis", Integr Cancer Ther, 23, pp.15347354231226115~ (2024)
19. Zeng P, "Integrating network pharmacology and experimental verification to investigate the pharmacological mechanisms of Buzhong Yiqi decoction in the treatment of non-small cell lung cancer", Chem Biol Drug Des, 103(1), pp.e14414~ (2024)
20. Chun J, "Bojungikki-Tang improves response to PD-L1 immunotherapy by regulating the tumor microenvironment in MC38 tumor-bearing mice", Front Pharmacol, 13, pp.901563~ (2022)
21. Wang N, "Inhibition of eukaryotic elongation factor-2 confers to tumor suppression by a herbal formulation Huanglian-Jiedu decoction in human hepatocellular carcinoma", J Ethnopharmacol, 164, pp.309~318 (2015)
22. Liu S, "Huang Lian Jie Du Decoction enhances the anti-tumor efficacy of immune checkpoint inhibitors by activating TLR7", 8 signalling in melanoma, 2024, pp.24(1), 156~
23. Yang HY, "Anti-inflammatory effects of Huanglian Jiedu Decoction and fermented Huanglian Jiedu Decoction", J Korean Orient Ophthalmol Otolaryngol Dermatol, 24(2), pp.1~15 (2011)
24. Takahashi K, "In vitro inhibitory effects of Kampo medicines on metabolic reactions catalyzed by human liver microsomes", J Clin Pharm Ther, 28(4), pp.319~327 (2003)
25. Jin SE, "Effects of herbal formulas Bojungikgi-Tang and Palmijihwang-Hwan on inflammation in RAW 264.7 cells and the activities of drug-metabolizing enzymes in human hepatic microsomes", J Med Food, 21(11), pp.1173~1187 (2018)
26. Zhou X, "Combination of Huanglian Jiedu Decoction and erlotinib delays growth and improves sensitivity of EGFR-mutated NSCLC cells in vitro and in vivo via STAT3", Bcl-2 signaling, 2021, pp.45(1), 217~229
27. Sato T, "Hochu-ekki-to(Bu-zhong-yi-qi-tang), a herbal medicine, enhances cisplatin-induced apoptosis in HeLa cells", Mol Med Rep, 12(4), pp.6215~6220 (2015)
28. Wang CY, "Conventional treatment integrated with Chinese herbal medicine improves the survival rate of patients with advanced non-small cell lung cancer", Complement Ther Med, 40, pp.29~36 (2018)
29. Lee MY, "Efficacy and safety of modified Huang-Lian-Jie-Du Decoction cream on cancer patients with skin side effects caused by EGFR inhibition", Processes, 9(7), pp.1081~ (2021)
30. Ren W, "Pharmacokinetic-pharmacodynamic analysis on inflammation rat model after oral administration of Huang Lian Jie Du decoction", PLoS One, 11(6), pp.e0156256~ (2016)
31. Wang J, "Berberine inhibits EGFR signaling and enhances the antitumor effects of EGFR inhibitors in gastric cancer", Oncotarget, 7(46), pp.76076~ (2016)

관련 논문AI추천